科济药业-B(02171)今日盘中大涨5.18%,引起了市场关注。
导致该股大涨的主要原因有以下两点: 1. MSCI公布了2月份指数审议结果,决定将科济药业-B股纳入MSCI全球小盘股指数,这将带来一定的被动资金流入。作为指数成份股,该股的投资价值和知名度将进一步提升。 2. 2月11日,南向资金再次大幅增持该股124.55万股,连续3日净买入。长期资金持续增持显示了对该股前景的看好,推动了股价上涨。
因此,指数调整和资金持续增持的双重利好因素,推动了科济药业-B股今日走出一波不错的涨幅。市场对该股长期前景表现出较大信心,成为生物科技板块的一枚看点股。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.